Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Klaire Yixin Fjæstad"'
Autor:
Marco Carretta, Marie-Louise Thorseth, Aimilia Schina, Dennis Alexander Agardy, Astrid Zedlitz Johansen, Kevin James Baker, Shawez Khan, Anne Mette Askehøj Rømer, Klaire Yixin Fjæstad, Hannes Linder, Dorota Ewa Kuczek, Marco Donia, Lars Grøntved, Daniel Hargbøl Madsen
Publikováno v:
Frontiers in Immunology, Vol 14 (2024)
Murine syngeneic tumor models have been used extensively for cancer research for several decades and have been instrumental in driving the discovery and development of cancer immunotherapies. These tumor models are very simplistic cancer models, but
Externí odkaz:
https://doaj.org/article/852d9960f5214e53a75dfd50634eb751
Autor:
Astrid Zedlitz Johansen, Marco Carretta, Marie-Louise Thorseth, Shawez Khan, Klaire Yixin Fjæstad, Christian Beltoft Brøchner, Hannes Linder, Christina Ankjærgaard, Marco Donia, Inna Chen, Dorte Lisbet Nielsen, Claus Preibisch Behrens, Daniel Hargbøl Madsen
Publikováno v:
Pharmaceutics, Vol 14, Iss 5, p 1046 (2022)
YKL-40 (also named chitinase 3 like-1 protein [CHI3L1]) is a secreted chitinase-like protein which is upregulated in cancers and suggested to have pro-tumorigenic activity. YKL-40 lacks enzymatic function, but it can bind carbohydrates such as chitin
Externí odkaz:
https://doaj.org/article/78186d8268bd442d8ea8f1b9fe7ac71e
Autor:
Klaire Yixin Fjæstad, Anne Mette Askehøj Rømer, Victor Goitea, Astrid Zedlitz Johansen, Marie-Louise Thorseth, Marco Carretta, Lars Henning Engelholm, Lars Grøntved, Niels Junker, Daniel Hargbøl Madsen
Publikováno v:
Fjæstad, K Y, Rømer, A M A, Goitea, V, Johansen, A Z, Thorseth, M L, Carretta, M, Engelholm, L H, Grøntved, L, Junker, N & Madsen, D H 2022, ' Blockade of beta-adrenergic receptors reduces cancer growth and enhances the response to anti-CTLA4 therapy by modulating the tumor microenvironment ', Oncogene, vol. 41, pp. 1364-1375 . https://doi.org/10.1038/s41388-021-02170-0
Fjæstad, K Y, Rømer, A M A, Goitea, V, Johansen, A Z, Thorseth, M L, Carretta, M, Engelholm, L H, Grøntved, L, Junker, N & Madsen, D H 2022, ' Blockade of beta-adrenergic receptors reduces cancer growth and enhances the response to anti-CTLA4 therapy by modulating the tumor microenvironment ', Oncogene, vol. 41, no. 9, pp. 1364-1375 . https://doi.org/10.1038/s41388-021-02170-0
Fjæstad, K Y, Rømer, A M A, Goitea, V, Johansen, A Z, Thorseth, M L, Carretta, M, Engelholm, L H, Grøntved, L, Junker, N & Madsen, D H 2022, ' Blockade of beta-adrenergic receptors reduces cancer growth and enhances the response to anti-CTLA4 therapy by modulating the tumor microenvironment ', Oncogene, vol. 41, no. 9, pp. 1364-1375 . https://doi.org/10.1038/s41388-021-02170-0
The development of immune checkpoint inhibitors (ICI) marks an important breakthrough of cancer therapies in the past years. However, only a limited fraction of patients benefit from such treatments, prompting the search for immune modulating agents
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::132a542c4788a27e2d7a5a87b406a60d
https://curis.ku.dk/ws/files/314704412/s41388_021_02170_0.pdf
https://curis.ku.dk/ws/files/314704412/s41388_021_02170_0.pdf
Autor:
Lars H. Engelholm, Niels Junker, Marco Carretta, Lars Grøntved, Anne Mette Askehøj Rømer, Daniel H. Madsen, Astrid Z. Johansen, Klaire Yixin Fjæstad, Victor Goitea, Marie-Louise Thorseth
The nonselective beta blocker, propranolol, which for decades has been prescribed for treatment of cardiovascular conditions, has recently been used successfully to treat metastatic angiosarcoma. These results have led to an orphan drug designation b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b06357d46e5854a12391ab50357c979d
https://doi.org/10.1101/2021.03.11.434711
https://doi.org/10.1101/2021.03.11.434711